-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial of SYH2066 tablets (this product) developed by the Group to treat respiratory syncytial virus (RSV) infection has been officially launched at the first research center in China.

Zhitongcaijing·10/22/2026 10:33:45
Listen to the news
Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase II clinical trial of SYH2066 tablets (this product) developed by the Group to treat respiratory syncytial virus (RSV) infection has been officially launched at the first research center in China.